Targeted Oncology™ announces first recipient of 2024 for its Oncology Icons award program
23 Abril 2024 - 9:46AM
Targeted Oncology™, a multimedia resource that offers engaging
content and expert opinions on standard and emerging treatments in
the field of oncology, is thrilled to announce the newest recipient
of the Oncology Icons award program. This program recognizes
individuals who have made exceptional contributions to the field of
oncology through their expertise, dedication and innovation.
Targeted Oncology is pleased to announce that
this year’s first recipient is an individual who has showcased
outstanding leadership and a profound dedication to enhancing
cancer care and actively serves as a source of inspiration for the
entire oncology community.
Sanjay K. Juneja, M.D., of Mary
Bird Perkins Cancer Center, is a medical oncologist in his hometown
of Baton Rouge, at the Baton Rouge General location. He graduated
from Louisiana State University with a bachelor of science degree
in biology and earned his doctor of medicine degree at Louisiana
State University School of Medicine in Shreveport. Dr. Juneja
completed a hematology/oncology fellowship at Feist-Weiller Cancer
Center in Shreveport. He is triple-board-certified in hematology,
medical oncology and internal medicine by the American Board of
Internal Medicine. Dr. Juneja’s professional memberships include
the Louisiana Oncology Society and Cancer Advocacy Group of
Louisiana. He served as the chief of Baton Rouge General’s oncology
service line from 2021-2023.
Dr. Juneja believes listening to and learning
from patients is central. “I am hoping that we have the grace...to
be OK with patients knowing and learning about their cancers and
asking questions. It is not only humbling, but it feeds that sense
of responsibility that I feel all the time,” Juneja said.
As a social media influencer, he partners with
various organizations using the handle @TheOncDoc, and often
participates in local and national media interviews and speaking
engagements. On his first nomination, Dr. Juneja was recognized in
the Baton Rouge Business Report’s Forty Under 40 list in November
2021.
To read more about Dr. Juneja’s notable
involvement in the oncology community, click here.
“We are honored to recognize the remarkable
contributions made by this year’s first Oncology Icons recipient,
Dr. Sanjay K. Juneja,” said Bobby Goldsmith, senior vice president,
corporate development. “Dr. Juneja exemplifies the pinnacle of
dedication, innovation and compassion in the field of cancer care,
and we commend his unwavering commitment.”
Targeted Oncology showcases detailed profiles of
the recipients through an article published in Targeted Therapies
in Oncology™ and on the Targeted Oncology website. This offers
readers a valuable chance to gain insights into their exceptional
journeys and contributions to the oncology community.
Submissions for the next 2024 Targeted Oncology
Icons Award are open. Nominate a physician making significant
contributions as a community oncologist here.
About Targeted Oncology
Targeted Oncology, a leading resource for
oncologists and hematologists, empowers practice-changing outcomes
through innovative learning formats and peer engagements. Its
journals, Targeted Therapies in Oncology and Peers &
Perspectives® in Oncology, are delivered 18 times a
year. TargetedOnc.com offers daily
content and an e-newsletter subscription and hosts 500-plus virtual
and in-person events annually, fostering engaging discussions among
oncology peers. Targeted Oncology is a brand of MJH
Life Sciences®, the largest privately held, independent,
full-service medical media company in North America delivering
trusted health care news.
Media Contact
Julia ParadizovaMJH Life
Sciencesjparadizova@mjhlifesciences.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/9ef2cd5c-b0ea-475b-ab76-8aca897a5588